S O L A N O
Product & Development
Solano is developing disease-modifying therapeutics to target neurodegenerative diseases by optimizing compounds, which target mitochondria, reduce oxidative damage, and promote neuronal survival. The company’s lead therapeutic compound, XJB-5-131 is being developed for the treatment of Huntington’s, Alzheimer’s and Parkinson’s.
Watch Pretty Ugly’s brand new video for “The Future Will Never Come”
Dropshadow's new video starring - YOU!
Listen to Mountain People’s new mix
Behind the scenes on the set of Fly Arm's chart topper "Nest"
VVTom remixes Ambrozious’s new track